Syros Pharmaceuticals Inc (SYRS)
4.99
-0.13
(-2.54%)
USD |
NASDAQ |
May 08, 16:00
4.99
0.00 (0.00%)
After-Hours: 17:09
Syros Pharmaceuticals Total Assets (Quarterly): 168.17M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 168.17M |
| September 30, 2023 | 147.80M |
| June 30, 2023 | 180.98M |
| March 31, 2023 | 205.32M |
| December 31, 2022 | 244.49M |
| September 30, 2022 | 284.72M |
| June 30, 2022 | 126.23M |
| March 31, 2022 | 152.08M |
| December 31, 2021 | 182.94M |
| September 30, 2021 | 208.04M |
| June 30, 2021 | 233.73M |
| March 31, 2021 | 260.63M |
| December 31, 2020 | 213.25M |
| September 30, 2020 | 133.34M |
| June 30, 2020 | 147.82M |
| March 31, 2020 | 161.40M |
| December 31, 2019 | 149.98M |
| Date | Value |
|---|---|
| September 30, 2019 | 143.83M |
| June 30, 2019 | 151.83M |
| March 31, 2019 | 88.43M |
| December 31, 2018 | 106.77M |
| September 30, 2018 | 120.63M |
| June 30, 2018 | 131.38M |
| March 31, 2018 | 128.10M |
| December 31, 2017 | 78.49M |
| September 30, 2017 | 88.68M |
| June 30, 2017 | 99.03M |
| March 31, 2017 | 78.02M |
| December 31, 2016 | 91.32M |
| September 30, 2016 | 100.41M |
| June 30, 2016 | 60.95M |
| March 31, 2016 | 70.82M |
| December 31, 2015 | 43.63M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
126.23M
Minimum
Jun 2022
284.72M
Maximum
Sep 2022
184.03M
Average
168.17M
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| PDS Biotechnology Corp | 59.39M |
| PAVmed Inc | 33.12M |
| Moderna Inc | 16.73B |
| Altimmune Inc | 210.64M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 151.51M |
| Shareholders Equity (Quarterly) | 16.66M |
| Debt to Equity Ratio | 2.474 |
| Current Ratio | 3.952 |
| Net Debt Paydown Yield | -0.07% |